Drugs / Bifidobacterium animalis subsp. lactis strain BB-12
Bifidobacterium animalis subsp. lactis strain BB-12
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00848003 Comparator | Oct 2009 → Jul 2011 | — | Georgetown University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium animalis subsp. lactis strain BB-12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00848003 ↗ |
| Known as | B. lactis | “Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12 (BB-12) probiotic supplemented yogurt, 4 ounces taken orally for 10 days” NCT00848003 ↗ |
| Known as | BB-12 | “Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12 (BB-12) probiotic supplemented yogurt, 4 ounces taken orally for 10 days” NCT00848003 ↗ |
| Modality | Other / unclassified | “Probiotic, BB-12, supplemented yogurt, 4 ounces taken orally for 10 days” NCT00848003 ↗ |
| Route | Oral | “taken orally” NCT00848003 ↗ |